Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - infusion, solution - 50 iu/ml - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 50 iu/ml

Singapore - English - HSA (Health Sciences Authority)

eshcol pharmaceutical group singapore pte ltd - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) - injection - 500 iu/ml - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) 500 iu/ml

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human antihepatitis b immunoglobulin - injection, solution - 250 i.u./ml - human antihepatitis b immunoglobulin 250 i.u./ml

Israel - English - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - solution for injection - human hepatitis b immunoglobulin 500 iu - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b virus (hbv) re-infection in hbsag and hbv-dna negative adult patients at least one week after liver transplantation for hepatitis b induced liver failure.hbv-dna negative status should be confirmed within the last 3 months prior to olt. patients should be hbsag negative before treatment start.the concomitant use of adequate virostatic agents should be considered as standard of hepatitis b re-infection prophylaxis.

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15-18% - hepatitis b immune globulin (human) 15-18%

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15-18% - hepatitis b immune globulin (human) 15-18%

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - hepatitis b immune globulin (human) - injection - 15 - 18% - hepatitis b immune globulin (human) 15 - 18%

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human antihepatitis b immunoglobulin - injection, solution - 1,000 i.u./4 ml - human antihepatitis b immunoglobulin 1,000 i.u./4 ml

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - human antihepatitis b immunoglobulin - injection, solution - 600 i.u./2.4 ml - human antihepatitis b immunoglobulin 600 i.u./2.4 ml

European Union - English - EMA (European Medicines Agency)

cangene europe limited - human hepatitis b immunoglobulin - immunization, passive; hepatitis b - specific immunoglobulins - immunoprophylaxis of hepatitis b - in case of accidental exposure in non-immunised subjects (including persons whose vaccination isincomplete or status unknown).- in haemodialysed patients, until vaccination has become effective.- in the newborn of a hepatitis b virus carrier-mother.- in subjects who did not show an immune response (no measurable hepatitis b antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis b.consideration should also be given to other official guidance on the appropriate use of human hepatitis b immunoglobulin for intramuscular use.